High prices not only pose a challenge to patient access, but they also raise a fundamental question: Are we creating these therapies the wrong way?
More than 13% of American adults -- or about 34 million people -- report knowing of at least one friend or family member in the past five years who died after not receiving needed medical treatment because they were unable to pay for it.
Two-year campaign opposing cost-saving plans featured secret payments, a widely criticized consultant's report, and celebrity drug cops.
David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs, will testify today before a U.S. House of Representatives subcommittee at the hearing, “Profits Over Consumers: Exposing How Pharmaceutical Corporations Game the System.”
"The pharmaceutical industry is now the most poorly regarded industry in Americans' eyes, ranking last on a list of 25 industries that Gallup tests annually."